67 related articles for article (PubMed ID: 2833065)
1. Potent 3-methylfentanyl analogs: morphine-like catalepsy and receptor binding characteristics.
Xu H; Yao YH; Zhu YC; Chen J; Chi ZQ
Zhongguo Yao Li Xue Bao; 1987 Jul; 8(4):289-92. PubMed ID: 2833065
[No Abstract] [Full Text] [Related]
2. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl and its analogs desensitize the cloned mu opioid receptor.
Bot G; Blake AD; Li S; Reisine T
J Pharmacol Exp Ther; 1998 Jun; 285(3):1207-18. PubMed ID: 9618424
[TBL] [Abstract][Full Text] [Related]
4. Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: evidence for different binding domains.
Ni Q; Xu H; Partilla JS; Stark PA; Carroll FI; Brine GA; Rothman RB
Synapse; 1993 Dec; 15(4):296-306. PubMed ID: 8153877
[TBL] [Abstract][Full Text] [Related]
5. (+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: evidence for pseudoallosteric modulation.
Xu H; Kim CH; Zhu YC; Weber RJ; Jacobson AE; Rice KC; Rothman RB
Neuropharmacology; 1991 May; 30(5):455-62. PubMed ID: 1650928
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding of (+)-cis methylfentanyl at the opiate receptor complex and behavioral correlates: evidence for a novel mechanism of action.
Band L; Bykov V; Greig N; Kim CH; Hauck-Newman A; Jacobson AE; Rice KC; Rothman RB
NIDA Res Monogr; 1989; 95():554-5. PubMed ID: 2561857
[No Abstract] [Full Text] [Related]
7. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice.
Höcker J; Böhm R; Meybohm P; Gruenewald M; Renner J; Ohnesorge H; Scholz J; Bein B
J Pharm Pharmacol; 2009 Jul; 61(7):901-10. PubMed ID: 19589232
[TBL] [Abstract][Full Text] [Related]
8. [Studies on structure-activity relationships and receptor binding feature for 3-methylfentanyl derivatives].
Weng JH; Xu XR; Zhu YC; Zhou J; Xu H; Chi ZQ
Yao Xue Xue Bao; 1990; 25(3):178-85. PubMed ID: 2173349
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor regulation in mice.
Yoburn BC; Billings B; Duttaroy A
J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
[TBL] [Abstract][Full Text] [Related]
11. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
Malec D; Langwiński R
Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl receptor assay. II. Utilization of a radioreceptor assay for the analysis of fentanyl analogs in urine.
Alburges ME; Hanson GR; Gibb JW; Sakashita CO; Rollins DE
J Anal Toxicol; 1992; 16(1):36-41. PubMed ID: 1322477
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors.
Liu ZH; He Y; Jin WQ; Chen XJ; Shen QX; Chi ZQ
Life Sci; 2004 Apr; 74(24):3001-8. PubMed ID: 15051423
[TBL] [Abstract][Full Text] [Related]
14. Interaction models of 3-methylfentanyl derivatives with mu opioid receptors.
Rong SB; Zhu YC; Jiang HL; Wang QM; Zhao SR; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):128-32. PubMed ID: 10072963
[TBL] [Abstract][Full Text] [Related]
15. Analgesic activity and selectivity for opioid receptors of enantiomers of ohmefentanyl.
Jin WQ; Wang ZX; Chen J; Chen XJ; Chi ZQ
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):421-4. PubMed ID: 9863164
[TBL] [Abstract][Full Text] [Related]
16. Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor.
Dosen-Micovic L; Ivanovic M; Micovic V
Bioorg Med Chem; 2006 May; 14(9):2887-95. PubMed ID: 16376082
[TBL] [Abstract][Full Text] [Related]
17. The effect of nitric oxide on fentanyl and haloperidol-induced catalepsy in mice.
Erkent U; Iskit AB; Onur R; Ilhan M
Eur J Anaesthesiol; 2006 Jul; 23(7):580-5. PubMed ID: 16507184
[TBL] [Abstract][Full Text] [Related]
18. The influence of gabaergic system on cataleptogenic action of analgesics and haloperidol.
Malec D; Langwiński R
Pol J Pharmacol Pharm; 1986; 38(5-6):501-7. PubMed ID: 3575168
[TBL] [Abstract][Full Text] [Related]
19. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic influences on opioids activity in rats.
Malec D; Langwiński R
Pol J Pharmacol Pharm; 1982; 34(1-3):85-92. PubMed ID: 6891961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
